Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parathyroid carcinoma.

Steven E Rodgers1, Nancy D Perrier

  • 1Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

Current Opinion in Oncology
|December 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same author

Hypoparathyroidism Post Thyroidectomy: Prevention, Evaluation, Management, and Application of Recent Guidelines.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Blood-Based Immunoglobulin-Bound Neoantigen Signatures Associated with MEN Type 1-Related Duodenopancreatic Neuroendocrine Tumor Progression.

Journal of the American College of Surgeons·2026
Same author

The shifting landscape of germline RET pathogenic variants with the introduction of panel testing.

Surgery·2025
Same author

Surgical management of metastatic adrenocortical carcinoma: Is there a role for multivisceral resection?

Surgery·2025
Same author

Letter to the Editor: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Parathyroid carcinoma is a rare cause of hyperparathyroidism, often linked to HRPT2 gene mutations. Surgical resection offers the best cure chance, with radiation potentially improving long-term survival.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Parathyroid carcinoma is an extremely rare endocrine malignancy, accounting for less than 1% of primary hyperparathyroidism cases.
  • The molecular etiology of parathyroid cancer remains largely unknown, hindering research and treatment development.

Purpose of the Study:

  • To review current knowledge on the etiology, diagnosis, and treatment of parathyroid carcinoma.
  • To highlight recent advances in understanding the genetic basis of parathyroid cancer.

Main Methods:

  • Review of existing literature on parathyroid carcinoma.
  • Analysis of genetic mutations, including the tumor suppressor gene HRPT2.
  • Examination of chromosomal regions with loss of heterozygosity in parathyroid carcinoma.

Related Experiment Videos

Main Results:

  • Mutations in the HRPT2 tumor suppressor gene are found in most studied parathyroid cancers.
  • Identification of chromosomal regions with loss of heterozygosity suggests additional tumor suppressor genes involved in parathyroid cancer development.
  • Associations with inherited syndromes and specific genetic lesions have been noted.

Conclusions:

  • Parathyroid carcinoma is rare, with largely unknown etiology, but HRPT2 mutations are significant.
  • Surgical resection (en bloc) is the primary curative approach.
  • External beam radiation may improve long-term survival; bisphosphonates and calcimimetics manage hypercalcemia symptomatically.